Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U, Silva-Sánchez J, López-Jácome LE, Hernández-Durán M, Colín-Castro CA, Sánchez-Pérez A, Rodríguez-Santiago J, Morfín-Otero R, Rodriguez-Noriega E, Velázquez-Acosta MD, Vázquez-Larios MDR, Feliciano-Guzmán JM, Rojas-Larios F, Ponce-De-Leon A, Lozano-Garcia M, Choy-Chang EV, López-Gutiérrez E, Molina-Jaimes A, Gil-Veloz M, Corte-Rojas RE, López-Ovilla I, Ramirez-Mis JL, Rodríguez-Balderas DE, Molina-Chavarria A, Padilla-Ibarra C, Quevedo-Ramos MA, Mireles-Dávalos CD, Rodríguez-Medina N, Rubio-Mendoza D, Córdova-Fletes C, Cruz-López F, Becerra-Montejano DA, Mercado-Longoria R, Martínez-Villarreal RT, Barlandas-Rendón NRE, Mena-Ramírez JP, Couoh-May CA, Alcaraz-Espejel M, Adame-Alvarez C, Hernández-Vicente L, Garza-González E. Garza-Ramos U, et al. Among authors: molina jaimes a. Microb Drug Resist. 2023 Jun;29(6):239-248. doi: 10.1089/mdr.2022.0226. Epub 2022 Dec 30. Microb Drug Resist. 2023. PMID: 36595348
Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting.
Ovilla-Martinez R, Cota-Rangel X, De La Peña-Celaya J, Alvarado-Zepeda MA, Jiménez Sastré A, Azuara Forcelledo H, Ordoñez Rodriguez B, Pulido Broca J, Molina Jaimes A, Muñiz-Carvajal A, Bahena García MM, Cervera Ceballos E, Zapata Canto NP, García Mendez JO, García Jímenez ON, Salas Heredia JA, Solis Soto J, Villalobos Mendez RA, Ignacio Ibarra G, Ledesma de la Cruz C, Araujo Martinez N, Juárez Lara J, Ceballos Zuñiga CO, Villaseñor Pérez FV, Herrera Garcia JC, Nuche Salazar P, Dominguez Paregrina A, Arizpe Bravo B, Enciso Figueroa G, Trujillo T, Miguel Álvarez A, García Gallegos DJ, Ortiz Arroyo A, Solorzano Soto CI, Jaramillo Ramírez HJ, De la Cruz Hernández I, De Gante Martínez S, Montesinos Gómez GE, Martínez Velasco S, García Graullera R, Vázquez López MA, Urbalejo Ceniceros VI, Lugo García Y, González Ávila AI, Duque Rodriguez J, Ruiz Luján R, Rodríguez Rivera VI, Soberanes Ramírez L, Baez-Islas PE. Ovilla-Martinez R, et al. Among authors: molina jaimes a. J Infect Dev Ctries. 2022 Jan 31;16(1):63-72. doi: 10.3855/jidc.15126. J Infect Dev Ctries. 2022. PMID: 35192523 Free article.
Increment Antimicrobial Resistance During the COVID-19 Pandemic: Results from the Invifar Network.
López-Jácome LE, Fernández-Rodríguez D, Franco-Cendejas R, Camacho-Ortiz A, Morfin-Otero MDR, Rodríguez-Noriega E, Ponce-de-León A, Ortiz-Brizuela E, Rojas-Larios F, Velázquez-Acosta MDC, Mena-Ramírez JP, Rodríguez-Zulueta P, Bolado-Martínez E, Quintanilla-Cazares LJ, Avilés-Benítez LK, Consuelo-Munoz S, Choy-Chang EV, Feliciano-Guzmán JM, Couoh-May CA, López-Gutiérrez E, Molina-Jaimes A, Rincón-Zuno J, Gil-Veloz M, Alcaraz-Espejel M, Corte-Rojas RE, Gómez-Espinosa J, Monroy-Colin VA, Morales-de-la-Peña CT, Aguirre-Burciaga E, López-Moreno LI, Martínez-Villarreal RT, Cetina-Umaña CM, Galindo-Méndez M, Soto-Nieto GI, Cobos-Canul DI, Moreno-Méndez MI, Tello-Gómez E, Romero-Romero D, Quintana-Ponce S, Peralta-Catalán R, Valadez-Quiroz A, Molina-Chavarría A, Padilla-Ibarra C, Barroso-Herrera-Y-Cairo IE, Duarte-Miranda LS, López-López DM, Escalante-Armenta SP, Osorio-Guzmán MJ, López-García M, Garza-Ramos U, Delgado-Enciso I, Garza-González E. López-Jácome LE, et al. Among authors: molina jaimes a. Microb Drug Resist. 2022 Mar;28(3):338-345. doi: 10.1089/mdr.2021.0231. Epub 2021 Dec 6. Microb Drug Resist. 2022. PMID: 34870473
A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period.
Garza-González E, Morfín-Otero R, Mendoza-Olazarán S, Bocanegra-Ibarias P, Flores-Treviño S, Rodríguez-Noriega E, Ponce-de-León A, Sanchez-Francia D, Franco-Cendejas R, Arroyo-Escalante S, Velázquez-Acosta C, Rojas-Larios F, Quintanilla LJ, Maldonado-Anicacio JY, Martínez-Miranda R, Ostos-Cantú HL, Gomez-Choel A, Jaime-Sanchez JL, Avilés-Benítez LK, Feliciano-Guzmán JM, Peña-López CD, Couoh-May CA, Molina-Jaimes A, Vázquez-Narvaez EG, Rincón-Zuno J, Rivera-Garay R, Galindo-Espinoza A, Martínez-Ramirez A, Mora JP, Corte-Rojas RE, López-Ovilla I, Monroy-Colin VA, Barajas-Magallón JM, Morales-De-la-Peña CT, Aguirre-Burciaga E, Coronado-Ramírez M, Rosales-García AA, Ayala-Tarín MD, Sida-Rodríguez S, Pérez-Vega BA, Navarro-Rodríguez A, Juárez-Velázquez GE, Cetina-Umaña CM, Mena-Ramírez JP, Canizales-Oviedo J, Moreno-Méndez MI, Romero-Romero D, Arévalo-Mejía A, Cobos-Canul DI, Aguilar-Orozco G, Silva-Sánchez J, Camacho-Ortiz A. Garza-González E, et al. Among authors: molina jaimes a. PLoS One. 2019 Mar 26;14(3):e0209865. doi: 10.1371/journal.pone.0209865. eCollection 2019. PLoS One. 2019. PMID: 30913243 Free PMC article.